|Articles|July 28, 2015
Janet Freeman-Daily on Genomic Testing for Lung Cancer Patients
Author(s)Janet Freeman-Daily
Janet Freeman-Daily, a patient with metastatic lung cancer and a CURE contributor, discusses the importance of genomic testing for patients with lung cancer.
Advertisement
Janet Freeman-Daily, a patient with metastatic lung cancer and a CURE contributor, discusses the importance of genomic testing for patients with lung cancer. We spoke with Freeman-Daily during the 2015 annual meeting of the American Society of Clinical Oncology (ASCO), a gathering of nearly 30,000 oncology professionals in Chicago.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
‘Full House’ Star Dave Coulier Talks Tongue Cancer Diagnosis
2
New Approach May Offer Stronger Treatment Effects in Metastatic Breast Cancer
3
Updated Treatment Options Improve Advanced HR+ Breast Cancer Outcomes
4
Stage 4 Pancreatic Cancer Survivor Shares Clinical Trial Path
5